According to Vor Biopharma's latest financial reports the company has $0.10 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.23 B | 10.98% |
2021-12-31 | $0.20 B | 327.43% |
2020-12-31 | $48.53 M | 650.68% |
2019-12-31 | $6.46 M | 596.02% |
2018-12-31 | $0.92 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | $0.31 B | 194.73% | ๐บ๐ธ USA |